344 related articles for article (PubMed ID: 27385168)
1. Role of Hepatic Drug Transporters in Drug Development.
Liu H; Sahi J
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S11-22. PubMed ID: 27385168
[TBL] [Abstract][Full Text] [Related]
2. Transporter-Enzyme Interplay: Deconvoluting Effects of Hepatic Transporters and Enzymes on Drug Disposition Using Static and Dynamic Mechanistic Models.
Varma MV; El-Kattan AF
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S99-S109. PubMed ID: 27385183
[TBL] [Abstract][Full Text] [Related]
3. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
Patel M; Taskar KS; Zamek-Gliszczynski MJ
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of New Chemical Entities as Substrates of Liver Transporters in the Pharmaceutical Industry: Response to Regulatory Requirements and Future Steps.
Okudaira N
J Pharm Sci; 2017 Sep; 106(9):2251-2256. PubMed ID: 28533120
[TBL] [Abstract][Full Text] [Related]
5. Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions.
Chu X; Chan GH; Evers R
J Pharm Sci; 2017 Sep; 106(9):2357-2367. PubMed ID: 28416420
[TBL] [Abstract][Full Text] [Related]
6. Prediction of pharmacokinetics and drug-drug interactions when hepatic transporters are involved.
Li R; Barton HA; Varma MV
Clin Pharmacokinet; 2014 Aug; 53(8):659-78. PubMed ID: 25056496
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
Feng B; Varma MV; Costales C; Zhang H; Tremaine L
Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
[TBL] [Abstract][Full Text] [Related]
8. Development of novel, 384-well high-throughput assay panels for human drug transporters: drug interaction and safety assessment in support of discovery research.
Tang H; Shen DR; Han YH; Kong Y; Balimane P; Marino A; Gao M; Wu S; Xie D; Soars MG; O'Connell JC; Rodrigues AD; Zhang L; Cvijic ME
J Biomol Screen; 2013 Oct; 18(9):1072-83. PubMed ID: 24062352
[TBL] [Abstract][Full Text] [Related]
9. Clinical Drug-Drug Interaction Evaluations to Inform Drug Use and Enable Drug Access.
Rekić D; Reynolds KS; Zhao P; Zhang L; Yoshida K; Sachar M; Piquette Miller M; Huang SM; Zineh I
J Pharm Sci; 2017 Sep; 106(9):2214-2218. PubMed ID: 28435142
[TBL] [Abstract][Full Text] [Related]
10. Transporter biology in drug approval: regulatory aspects.
Maeda K; Sugiyama Y
Mol Aspects Med; 2013; 34(2-3):711-8. PubMed ID: 23506904
[TBL] [Abstract][Full Text] [Related]
11. Impact of hepatic uptake transporters on pharmacokinetics and drug-drug interactions: use of assays and models for decision making in the pharmaceutical industry.
Soars MG; Webborn PJ; Riley RJ
Mol Pharm; 2009; 6(6):1662-77. PubMed ID: 19402709
[TBL] [Abstract][Full Text] [Related]
12. Impact of Transporter Polymorphisms on Drug Development: Is It Clinically Significant?
McLean C; Wilson A; Kim RB
J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S40-58. PubMed ID: 27385178
[TBL] [Abstract][Full Text] [Related]
13. In Vitro-In Vivo Extrapolation of Metabolism- and Transporter-Mediated Drug-Drug Interactions-Overview of Basic Prediction Methods.
Yoshida K; Zhao P; Zhang L; Abernethy DR; Rekić D; Reynolds KS; Galetin A; Huang SM
J Pharm Sci; 2017 Sep; 106(9):2209-2213. PubMed ID: 28456729
[TBL] [Abstract][Full Text] [Related]
14. Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms.
Yoshida K; Maeda K; Sugiyama Y
Annu Rev Pharmacol Toxicol; 2013; 53():581-612. PubMed ID: 23140240
[TBL] [Abstract][Full Text] [Related]
15. Beyond the ITC White Paper: emerging sciences in drug transporters and opportunities for drug development.
Lai Y; Hsiao P
Curr Pharm Des; 2014; 20(10):1577-94. PubMed ID: 23789952
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced liver injury: the role of drug metabolism and transport.
Corsini A; Bortolini M
J Clin Pharmacol; 2013 May; 53(5):463-74. PubMed ID: 23436293
[TBL] [Abstract][Full Text] [Related]
17. Roles of Hepatic Drug Transporters in Drug Disposition and Liver Toxicity.
Pan G
Adv Exp Med Biol; 2019; 1141():293-340. PubMed ID: 31571168
[TBL] [Abstract][Full Text] [Related]
18. The role of hepatic transporters in drug elimination.
Funk C
Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):363-79. PubMed ID: 18433342
[TBL] [Abstract][Full Text] [Related]
19. Effect of Liver Disease on Hepatic Transporter Expression and Function.
Thakkar N; Slizgi JR; Brouwer KLR
J Pharm Sci; 2017 Sep; 106(9):2282-2294. PubMed ID: 28465155
[TBL] [Abstract][Full Text] [Related]
20. Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification System.
El-Kattan AF; Varma MVS
Drug Metab Dispos; 2018 May; 46(5):729-739. PubMed ID: 29496721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
